{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tinzaparin+sodium&page=2", "query": { "intervention": "Tinzaparin sodium", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 44, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tinzaparin+sodium&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tinzaparin+sodium&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T20:47:32.837Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00718224", "title": "Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thromboembolism" ], "interventions": [ { "name": "Semuloparin sodium", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1150, "start_date": "2008-07", "completion_date": "2009-05", "has_results": false, "last_update_posted_date": "2013-01-23", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00718224" }, { "nct_id": "NCT04505774", "title": "Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "theraputic heparin", "type": "DRUG" }, { "name": "prophylactic heparin", "type": "DRUG" }, { "name": "P2Y12", "type": "DRUG" }, { "name": "Crizanlizumab Injection", "type": "DRUG" }, { "name": "SGLT2 inhibitor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Matthew Neal MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3591, "start_date": "2020-09-04", "completion_date": "2024-01-26", "has_results": true, "last_update_posted_date": "2024-12-30", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 65 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fontana", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04505774" }, { "nct_id": "NCT02923115", "title": "Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pulmonary Embolism", "Thrombotic Disease" ], "interventions": [ { "name": "DS-1040b", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 134, "start_date": "2016-06-23", "completion_date": "2019-08-05", "has_results": true, "last_update_posted_date": "2023-04-19", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 15, "location_summary": "Mobile, Alabama • Beverly Hills, California • San Diego, California + 12 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02923115" }, { "nct_id": "NCT00679588", "title": "Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thromboembolism" ], "interventions": [ { "name": "Semuloparin Sodium", "type": "DRUG" }, { "name": "Enoxaparin sodium", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4413, "start_date": "2008-04", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2013-12-16", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Corlton, California • Huntingdon Beach, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Corlton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00679588" }, { "nct_id": "NCT04372589", "title": "Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19", "Pneumonia" ], "interventions": [ { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Manitoba", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2020-05-20", "completion_date": "2021-05-17", "has_results": false, "last_update_posted_date": "2021-07-27", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 13, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Jefferson, Louisiana + 10 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Jefferson", "state": "Louisiana" }, { "city": "Portland", "state": "Maine" }, { "city": "Dearborn", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04372589" }, { "nct_id": "NCT00182143", "title": "PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Critical Illness", "Deep Venous Thrombosis" ], "interventions": [ { "name": "LMWH (Fragmin, dalteparin)", "type": "DRUG" }, { "name": "Unfractionated Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "McMaster University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3659, "start_date": "2006-05", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2011-01-10", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 4, "location_summary": "Rochester, Minnesota • St Louis, Missouri • Providence, Rhode Island + 1 more", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Providence", "state": "Rhode Island" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00182143" }, { "nct_id": "NCT00952380", "title": "Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Venous Thromboembolism" ], "interventions": [ { "name": "dalteparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 38, "start_date": "2009-08", "completion_date": "2018-03", "has_results": true, "last_update_posted_date": "2019-04-16", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 17, "location_summary": "Aurora, Colorado • Washington D.C., District of Columbia • Jacksonville, Florida + 6 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00952380" }, { "nct_id": "NCT05848713", "title": "AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community-acquired Pneumonia" ], "interventions": [ { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Manitoba", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4000, "start_date": "2023-10-10", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 6, "location_summary": "Chicago, Illinois • Jefferson, Louisiana • Portland, Maine + 3 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Jefferson", "state": "Louisiana" }, { "city": "Portland", "state": "Maine" }, { "city": "Dearborn", "state": "Michigan" }, { "city": "Camden", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05848713" }, { "nct_id": "NCT03081169", "title": "Timing of VTE Prophylaxis in TBI", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "TBI (Traumatic Brain Injury)", "VTE (Venous Thromboembolism)" ], "interventions": [ { "name": "Enoxaparin Sodium 150 MG/ML Prefilled Syringe", "type": "DRUG" }, { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2017-04-03", "completion_date": "2019-08-12", "has_results": false, "last_update_posted_date": "2019-08-16", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 1, "location_summary": "Maywood, Illinois", "locations": [ { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03081169" }, { "nct_id": "NCT04406389", "title": "Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Enoxaparin sodium", "type": "DRUG" }, { "name": "Unfractionated heparin", "type": "DRUG" }, { "name": "Fondapariniux", "type": "DRUG" }, { "name": "Argatroban", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2020-10-13", "completion_date": "2022-04-21", "has_results": true, "last_update_posted_date": "2023-09-21", "last_synced_at": "2026-10-08T20:47:32.837Z", "location_count": 2, "location_summary": "Brooklyn, New York • New York, New York", "locations": [ { "city": "Brooklyn", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04406389" } ] }